Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Tritanrix-HepB/Hib-MenAC Booster in Toddlers
NCT00228917Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2005
- Primary completion
- Jan 2006
- Modality
- Split/Subunit Vaccines
- Countries
- 2
01
Overview
A Phase 3 trial of Tritanrix-HepB/Hib-MenAC in diphtheria, Tetanus, pertussis, hepatitis B (HBV), Haemophilus influenzae type b infection (Hib), sponsored by GSK. Started Jun 2005; status: completed.
02
Drugs
Tritanrix-HepB/Hib-MenAC
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT00228917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00228917.